CV

Chiesi Ventures

North America, Massachusetts, United States, Boston

Description

Chiesi Ventures is a venture capital firm that invests in early stage opportunities operating in the area of rare and orphan disorders.

Investor Profile

Chiesi Ventures has made 17 investments, with 0 in the past 12 months and 6% as lead.

Stage Focus

  • Series B (41%)
  • Series A (41%)
  • Series C (12%)
  • Series Unknown (6%)

Country Focus

  • United States (88%)
  • Spain (12%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Therapeutics
  • Medical
  • Genetics
  • Medical Device
  • Health Diagnostics
  • Life Science
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Chiesi Ventures frequently co-invest with?

Ysios Capital
Europe, Pais Vasco, Spain, San Sebastian
Co-Investments: 5
Sanderling Ventures
North America, California, United States, San Mateo
Co-Investments: 3
Advent Life Sciences
Europe, England, United Kingdom, London
Co-Investments: 3
Lundbeckfonden Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 3
RiverVest
North America, Missouri, United States, St Louis
Co-Investments: 3
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 3
Arix Bioscience
Europe, England, United Kingdom, London
Co-Investments: 3
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 3
Pappas Capital
North America, North Carolina, United States, Durham
Co-Investments: 5
Pappas Ventures
North America, North Carolina, United States, Durham
Co-Investments: 3

Which angels does Chiesi Ventures often collaborate with?

HT
Europe, Noord-Brabant, The Netherlands, Tilburg
Shared Deals: 1

What are some of recent deals done by Chiesi Ventures?

Glycomine

San Francisco, California, United States

Glycomine is an early-stage biotech working on replacement therapies for rare diseases.

BiotechnologyPharmaceuticalTherapeutics
Series BJun 23, 2021
Amount Raised: $35,000,000
Aura Biosciences

Cambridge, Massachusetts, United States

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

BiotechnologyHealth CarePharmaceutical
Series UnknownMar 22, 2021
Amount Raised: $80,000,000
Reneo Pharmaceuticals

San Diego, California, United States

Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.

BiotechnologyMedicalPharmaceutical
Series BDec 9, 2020
Amount Raised: $95,000,000
4D Molecular Therapeutics

Emeryville, California, United States

4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

BiotechnologyGenetics
Series CJun 16, 2020
Amount Raised: $75,000,000
Glycomine

San Francisco, California, United States

Glycomine is an early-stage biotech working on replacement therapies for rare diseases.

BiotechnologyPharmaceuticalTherapeutics
Series BAug 7, 2019
Amount Raised: $33,000,000
Mirum Pharmaceuticals

Foster City, California, United States

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series ANov 7, 2018
Amount Raised: $120,000,000
CuraSen Therapeutics

San Carlos, California, United States

CuraSen Therapeutics is a biopharmaceutical company that develops orphan drugs to treat neurodegenerative diseases

BiotechnologyMedical DeviceTherapeutics
Series AOct 17, 2018
Amount Raised: $54,500,000
VelosBio

San Diego, California, United States

VelosBio is a next-generation oncology company, developing novel antibody-drug conjugates to treat haematological cancers.

BiotechnologyHealth CareMedicalOncology
Series AOct 1, 2018
Amount Raised: $58,000,000
Minoryx Therapeutics

Barcelona, Catalonia, Spain

Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.

BiotechnologyGeneticsHealth CareMedicalPharmaceutical
Series BSep 26, 2018
Amount Raised: $25,021,292
4D Molecular Therapeutics

Emeryville, California, United States

4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

BiotechnologyGenetics
Series BSep 5, 2018
Amount Raised: $90,000,000